Xianghua Fu Selected Research

Uric Acid (Urate)

1/2021	FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
2/2019	Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianghua Fu Research Topics

Disease

12	Myocardial Infarction 11/2020 - 09/2009
11	ST Elevation Myocardial Infarction 01/2021 - 01/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2014
5	Heart Failure 04/2016 - 07/2010
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2021 - 02/2019
2	Inflammation (Inflammations) 01/2021 - 12/2015
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 08/2020
2	Diabetes Mellitus 08/2020 - 02/2019
2	Hypertension (High Blood Pressure) 08/2020 - 02/2019
2	Chest Pain (Chest Pains) 01/2019 - 11/2015
2	Acute Coronary Syndrome 01/2017 - 08/2013
2	Renal Insufficiency (Renal Failure) 04/2016 - 07/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2015 - 03/2015
1	Left Ventricular Dysfunction 08/2021
1	Ventricular Remodeling 08/2021
1	Anterior Wall Myocardial Infarction 08/2021
1	Chronic Renal Insufficiency 02/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Insulin Resistance 01/2021
1	Atrial Fibrillation 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Pulmonary Hypertension 10/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 08/2020
1	Hyperuricemia 08/2020
1	Atrial Heart Septal Defects (Atrial Septal Defect) 01/2020
1	Shock 12/2015
1	Unstable Angina 12/2015
1	Poisoning 12/2015
1	Infarction (Infarctions) 11/2015
1	Thrombosis (Thrombus) 09/2015
1	Inferior Wall Myocardial Infarction 09/2015
1	Cardiac Arrhythmias (Arrythmia) 12/2014
1	Hemorrhage 08/2013
1	Ischemia 05/2013
1	Atherosclerosis 09/2009

Drug/Important Bio-Agent (IBA)

5	omega-Chloroacetophenone (Mace)IBA 01/2017 - 01/2014
5	anisodamineIBA 06/2016 - 01/2011
4	C-Reactive ProteinIBA 01/2021 - 12/2015
4	Troponin IIBA 01/2021 - 02/2019
4	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2016 - 07/2010
3	oxidized low density lipoproteinIBA 01/2021 - 02/2019
2	Uric Acid (Urate)IBA 01/2021 - 02/2019
2	Natriuretic PeptidesIBA 01/2021 - 02/2019
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 08/2020
2	CholesterolIBA 08/2020 - 09/2009
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 10/2014
2	N(2)-(3-trifluoromethylphenyl)guanineIBA 01/2020 - 09/2015
2	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2016 - 11/2015
1	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021
1	CreatinineIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	Long Noncoding RNAIBA 12/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2020
1	ferulic acid (sodium ferulate)IBA 10/2020
1	LDL CholesterolIBA 08/2020
1	Sirolimus (Rapamycin)FDA Link 08/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	IsoenzymesIBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2017
1	Saline SolutionIBA 06/2016
1	Phosphorus (Red Phosphorus)IBA 12/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015
1	Alprostadil (Muse)FDA LinkGeneric 12/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2015
1	AlkaloidsIBA 12/2015
1	MB 3 (MB-3)IBA 11/2015
1	Nicorandil (SG 75)IBA 09/2015
1	alkylate 215 (A 215)IBA 03/2015
1	Diltiazem (Cardizem)FDA LinkGeneric 12/2014
1	Tirofiban (Aggrastat)FDA Link 08/2013
1	reteplase FDA Link 05/2013
1	PotassiumIBA 09/2012
1	Atorvastatin (Lipitor)FDA Link 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2009
1	Simvastatin (Zocor)FDA LinkGeneric 09/2009

Therapy/Procedure

20	Percutaneous Coronary Intervention 02/2021 - 07/2010
4	Stents 01/2021 - 03/2015
4	Length of Stay 09/2015 - 07/2010
3	Drug-Eluting Stents 02/2021 - 02/2019
2	Intravenous Infusions 11/2015 - 01/2011
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2021
1	Septal Occluder Device 01/2020
1	Intravenous Administration 12/2015
1	Intravenous Injections 11/2015
1	Patient Readmission 03/2015
1	Injections 12/2014
1	Ischemic Postconditioning 10/2014
1	Punctures 01/2014
1	Therapeutics 09/2009